10-Q Filing

REGENXBIO Inc. CIK: 1590877 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-061144`
Period End Date	20230930
Filing Date	20231108
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	rgnx-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 81 Cash Flow Statement 70 Stockholders Equity 36

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$118.54M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$53.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$96.95M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$267.69M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$248.84M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$28.04M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$28.08M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$13.90M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$12.56M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$23.35M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.30M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.99M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$9.35M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$365.84M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.30M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.99M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$415.98M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$200.56M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$62.64M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$1.50M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$1.08M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$135.53M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$141.69M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$61.77M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$65.12M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.25M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.40M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.67M	USD	Point-in-time
Total assets	`Assets`	$633.79M	USD	Point-in-time
Total assets	`Assets`	$833.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.86M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.21M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$45.66M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$46.79M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$442.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.83M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.64M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$52.75M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$48.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$127.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$130.43M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$84.06M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$88.80M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$53.10M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$89.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$8.83M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$6.19M	USD	Point-in-time
Total liabilities	`Liabilities`	$270.69M	USD	Point-in-time
Total liabilities	`Liabilities`	$317.07M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2023 and December 31, 2022; 43,621 and 43,299 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2023 and December 31, 2022; 43,621 and 43,299 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.01B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$973.14M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-7.41M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-642.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-441.55M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$363.10M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$405.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$563.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$764.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$516.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$630.52M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$633.79M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$833.27M	USD	Point-in-time

Income Statement 81 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$68.03M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$81.38M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$28.91M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$26.51M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$13.09M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$25.98M	USD	3 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$41.76M	USD	3 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$12.39M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$176.59M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$58.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$179.95M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$63.31M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$20.92M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$64.07M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$23.08M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$69.42M	USD	3 Qtrs
Other operating expenses	`OtherOperatingExpenses`	$279.00K	USD	3 Qtrs
Other operating expenses	`OtherOperatingExpenses`	$703.00K	USD	3 Qtrs
Other operating expenses	`OtherOperatingExpenses`	$220.00K	USD	1 Quarter
Other operating expenses	`OtherOperatingExpenses`	$229.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$272.25M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$93.87M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$97.56M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$286.48M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-64.96M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-204.22M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-205.10M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-71.05M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$18.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$265.00K	USD	3 Qtrs
Interest income from licensing	`InterestIncomeFromLicencing`	$56.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$166.00K	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$3.36M	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$4.66M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$8.95M	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$1.50M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.95M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.50M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.62M	USD	1 Quarter
Interest expense	`InterestExpense`	$18.94M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$3.62M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-15.32M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-4.44M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$3.09M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-200.60M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-75.48M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-61.87M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-220.43M	USD	3 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-41.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-200.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-220.39M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-75.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-61.87M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$7.99M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.49M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$2.69M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-15.69M	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-15.69M	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$7.99M	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.69M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.49M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-59.18M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-78.98M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-236.07M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-192.62M	USD	3 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-4.60	USD	3 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-1.75	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-1.41	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-5.11	USD	3 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-4.60	USD	3 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.75	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-5.11	USD	3 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.41	USD	1 Quarter
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,644.00	shares	3 Qtrs
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,251.00	shares	1 Quarter
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,945.00	shares	1 Quarter
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,103.00	shares	3 Qtrs
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,251.00	shares	1 Quarter
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,644.00	shares	3 Qtrs
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,103.00	shares	3 Qtrs
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,945.00	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-200.60M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-220.39M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.38M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.93M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$8.78M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.98M	USD	3 Qtrs
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-929.00K	USD	3 Qtrs
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.81M	USD	3 Qtrs
Net loss (gain) on investments	`GainLossOnInvestments`	$2.21M	USD	3 Qtrs
Net loss (gain) on investments	`GainLossOnInvestments`	$-79.00K	USD	3 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$264.00K	USD	3 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$166.00K	USD	3 Qtrs
Non-cash interest expense	`NonCashInterestExpense`	$-569.00K	USD	3 Qtrs
Non-cash interest expense	`NonCashInterestExpense`	$767.00K	USD	3 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-540.00K	USD	3 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-165.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$22.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-566.00K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-3.93M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-1.34M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$13.57M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-2.75M	USD	3 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-3.08M	USD	3 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-4.25M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.73M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$1.92M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-4.01M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$16.88M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.55M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-28.24M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-1.22M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$2.82M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-5.00M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-50.00K	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-2.64M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$7.94M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-168.12M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-177.65M	USD	3 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$67.92M	USD	3 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$172.91M	USD	3 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$231.75M	USD	3 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$159.01M	USD	3 Qtrs
Sales of equity securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$1.98M	USD	3 Qtrs
Sales of equity securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$524.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.25M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.83M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-38.63M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$156.97M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.31M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.76M	USD	3 Qtrs
Taxes paid related to net settlement of stock-based awards	`TaxesPaidRelatedToNetSettlementOfStockBasedAwards`	$419.00K	USD	3 Qtrs
Taxes paid related to net settlement of stock-based awards	`TaxesPaidRelatedToNetSettlementOfStockBasedAwards`	$284.00K	USD	3 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$1.83M	USD	3 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$1.74M	USD	3 Qtrs
Proceeds from private placement of common stock, net of issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$4.87M	USD	3 Qtrs
Offering expenses related to at-the-market offering program	`OfferingExpensesRelatedToAtTheMarketOfferingProgram`	$51.00K	USD	3 Qtrs
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$24.14M	USD	3 Qtrs
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$30.55M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-23.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-19.92M	USD	3 Qtrs
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-43.68M	USD	3 Qtrs
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-226.66M	USD	3 Qtrs
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$55.30M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$120.57M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$98.98M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$55.30M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$120.57M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$98.98M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$363.10M	USD	Point-in-time
Balances	`StockholdersEquity`	$405.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$563.82M	USD	Point-in-time
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$516.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$630.52M	USD	Point-in-time
Vesting of restricted stock units, net of tax	`VestingOfRestrictedStockUnits`	$-419.00K	USD	3 Qtrs
Vesting of restricted stock units, net of tax	`VestingOfRestrictedStockUnits`	$-284.00K	USD	3 Qtrs
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.76M	USD	3 Qtrs
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.31M	USD	3 Qtrs
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$92.00K	USD	1 Quarter
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$917.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.83M	USD	3 Qtrs
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.24M	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.74M	USD	3 Qtrs
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.12M	USD	1 Quarter
Issuance of common stock upon private placement	`StockIssuedDuringPeriodValueNewIssues`	$4.87M	USD	3 Qtrs
Issuance of common stock upon private placement	`StockIssuedDuringPeriodValueNewIssues`	$4.87M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.22M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$31.38M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$31.93M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.24M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.69M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-15.69M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$7.99M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-3.49M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-220.39M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-75.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-61.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-200.60M	USD	3 Qtrs
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$563.82M	USD	Point-in-time
Balances	`StockholdersEquity`	$516.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$363.10M	USD	Point-in-time
Balances	`StockholdersEquity`	$405.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$630.52M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.